Shop Apotheke Europe N.V
Redcare Pharmacy NV operates the online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, France, and Czechia. It offers prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. … Read more
Shop Apotheke Europe N.V (SHPPF) - Net Assets
Latest net assets as of September 2025: $522.02 Million USD
Based on the latest financial reports, Shop Apotheke Europe N.V (SHPPF) has net assets worth $522.02 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.22 Billion) and total liabilities ($697.84 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $522.02 Million |
| % of Total Assets | 42.79% |
| Annual Growth Rate | 35.47% |
| 5-Year Change | 19.95% |
| 10-Year Change | 20638.88% |
| Growth Volatility | 1057.54 |
Shop Apotheke Europe N.V - Net Assets Trend (2013–2024)
This chart illustrates how Shop Apotheke Europe N.V's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Shop Apotheke Europe N.V (2013–2024)
The table below shows the annual net assets of Shop Apotheke Europe N.V from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $509.97 Million | -7.62% |
| 2023-12-31 | $552.03 Million | +55.66% |
| 2022-12-31 | $354.63 Million | -14.63% |
| 2021-12-31 | $415.41 Million | -2.29% |
| 2020-12-31 | $425.14 Million | +82.65% |
| 2019-12-31 | $232.76 Million | +8.78% |
| 2018-12-31 | $213.97 Million | -10.46% |
| 2017-12-31 | $238.97 Million | +156.28% |
| 2016-12-31 | $93.25 Million | +3691.99% |
| 2015-12-31 | $2.46 Million | -87.74% |
| 2014-12-31 | $20.06 Million | +10.93% |
| 2013-12-31 | $18.08 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Shop Apotheke Europe N.V's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 32428500000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $402.00K | 0.08% |
| Other Comprehensive Income | $52.97 Million | 10.94% |
| Other Components | $754.90 Million | 155.98% |
| Total Equity | $483.98 Million | 100.00% |
Shop Apotheke Europe N.V Competitors by Market Cap
The table below lists competitors of Shop Apotheke Europe N.V ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shenzhen Hopewind Elec Co Ltd
SHG:603063
|
$1.48 Billion |
|
TAL Education Group
NYSE:TAL
|
$1.48 Billion |
|
Beijing YanDong MicroElectronic Co. Ltd. A
SHG:688172
|
$1.48 Billion |
|
Cetc Potevio Science&Technology Co Ltd
SHE:002544
|
$1.48 Billion |
|
Aster DM Healthcare Limited
NSE:ASTERDM
|
$1.48 Billion |
|
Axogen Inc
NASDAQ:AXGN
|
$1.48 Billion |
|
Anhui XDLK Microsystem Corp. Ltd. A
SHG:688582
|
$1.48 Billion |
|
Eurocommercial Properties N.V.
AS:ECMPA
|
$1.48 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shop Apotheke Europe N.V's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 522,194,000 to 483,981,000, a change of -38,213,000 (-7.3%).
- Net loss of 45,464,000 reduced equity.
- New share issuances of 3,966,000 increased equity.
- Other comprehensive income decreased equity by 15,332,000.
- Other factors increased equity by 18,617,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-45.46 Million | -9.39% |
| Share Issuances | $3.97 Million | +0.82% |
| Other Comprehensive Income | $-15.33 Million | -3.17% |
| Other Changes | $18.62 Million | +3.85% |
| Total Change | $- | -7.32% |
Book Value vs Market Value Analysis
This analysis compares Shop Apotheke Europe N.V's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.80x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 70.05x to 5.80x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | $1.99 | $139.63 | x |
| 2014-12-31 | $2.21 | $139.63 | x |
| 2015-12-31 | $0.27 | $139.63 | x |
| 2016-12-31 | $10.28 | $139.63 | x |
| 2017-12-31 | $25.16 | $139.63 | x |
| 2018-12-31 | $17.76 | $139.63 | x |
| 2019-12-31 | $17.82 | $139.63 | x |
| 2020-12-31 | $29.57 | $139.63 | x |
| 2021-12-31 | $23.23 | $139.63 | x |
| 2022-12-31 | $19.72 | $139.63 | x |
| 2023-12-31 | $27.14 | $139.63 | x |
| 2024-12-31 | $24.06 | $139.63 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shop Apotheke Europe N.V utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -9.39%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1.92%
- • Asset Turnover: 2.36x
- • Equity Multiplier: 2.07x
- Recent ROE (-9.39%) is above the historical average (-48.76%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -15.66% | -5.12% | 2.15x | 1.42x | $-4.64 Million |
| 2014 | -25.10% | -5.95% | 2.87x | 1.47x | $-7.04 Million |
| 2015 | -428.95% | -8.40% | 2.94x | 17.39x | $-10.79 Million |
| 2016 | -19.78% | -10.40% | 1.47x | 1.29x | $-27.77 Million |
| 2017 | -8.94% | -7.52% | 0.95x | 1.25x | $-45.25 Million |
| 2018 | -15.71% | -6.23% | 1.54x | 1.64x | $-55.01 Million |
| 2019 | -15.58% | -5.17% | 1.64x | 1.84x | $-59.55 Million |
| 2020 | -3.94% | -1.73% | 1.80x | 1.26x | $-59.28 Million |
| 2021 | -17.86% | -7.00% | 1.35x | 1.89x | $-115.73 Million |
| 2022 | -21.89% | -6.45% | 1.65x | 2.06x | $-113.11 Million |
| 2023 | -2.31% | -0.67% | 1.76x | 1.96x | $-64.26 Million |
| 2024 | -9.39% | -1.92% | 2.36x | 2.07x | $-93.86 Million |
Industry Comparison
This section compares Shop Apotheke Europe N.V's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $239,198,060
- Average return on equity (ROE) among peers: -6.39%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shop Apotheke Europe N.V (SHPPF) | $522.02 Million | -15.66% | 1.34x | $1.48 Billion |
| Alibaba Health Information Technology Limited (ALBBY) | $1.12 Billion | -18.54% | 0.50x | $12.50 Billion |
| Allstar Health Brands Inc (ALST) | $-9.92 Million | 0.00% | 0.00x | $3.83 |
| Bimi International Medical Inc (BIMI) | $-409.66K | 0.00% | 0.00x | $296.83 |
| Blum Holdings Inc (BLMH) | $-4.74 Million | 0.00% | 0.00x | $8.97 Million |
| China Jo-Jo Drugstores Inc (CJJD) | $26.66 Million | -21.17% | 1.52x | $5.94 Million |
| Clicks Group Ltd (CLCGY) | $1.13 Billion | 41.98% | 2.72x | $4.80 Billion |
| China BCT Pharmacy Group Inc (CNBI) | $134.27 Million | 15.68% | 0.82x | $0.96 |
| Dalrada Financial Corp (DFCO) | $4.40 Million | -81.82% | 0.55x | $1.57 Million |
| Health Advance Inc (HADV) | $-105.34K | 0.00% | 0.00x | $25.40K |
| Healthwarehouse.Com (HEWA) | $-3.10 Million | 0.00% | 0.00x | $720.96 |